CASI PHARMACEUTICALS, INC. (CASIF) Shareholders’ equity 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) shareholders’ equity at each fiscal year-end, per SEC filings.
-$37.3MFY2025 · since FY2020: $81.5M → -$37.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.3M | -2114.2% |
| FY2024 | $1.9M | -92.3% |
| FY2023 | $24.2M | -45.8% |
| FY2022 | $44.6M | -47.3% |
| FY2021 | $84.5M | +3.6% |
| FY2020 | $81.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF overview →